These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 17043543)
1. Accelerated cutaneous nodulosis during infliximab therapy in a patient with rheumatoid arthritis. Mackley CL; Ostrov BE; Ioffreda MD J Clin Rheumatol; 2004 Dec; 10(6):336-8. PubMed ID: 17043543 [TBL] [Abstract][Full Text] [Related]
2. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis. Williams FM; Cohen PR; Arnett FC J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):359-62. PubMed ID: 9703153 [TBL] [Abstract][Full Text] [Related]
3. Successful treatment of methotrexate induced nodulosis with D-penicillamine. Dash S; Seibold JR; Tiku ML J Rheumatol; 1999 Jun; 26(6):1396-9. PubMed ID: 10381063 [TBL] [Abstract][Full Text] [Related]
4. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. Combe B; Didry C; Gutierrez M; Anaya JM; Sany J Eur J Med; 1993 Mar; 2(3):153-6. PubMed ID: 8261056 [TBL] [Abstract][Full Text] [Related]
5. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases. Kerstens PJ; Boerbooms AM; Jeurissen ME; Fast JH; Assmann KJ; van de Putte LB J Rheumatol; 1992 Jun; 19(6):867-71. PubMed ID: 1404122 [TBL] [Abstract][Full Text] [Related]
6. Nodulosis in systemic onset juvenile idiopathic arthritis: an uncommon event with spontaneous resolution. Abdwani R; Scuccumarri R; Duffy K; Duffy CM Pediatr Dermatol; 2009; 26(5):587-91. PubMed ID: 19840317 [TBL] [Abstract][Full Text] [Related]
7. Rheumatoid nodule. García-Patos V Semin Cutan Med Surg; 2007 Jun; 26(2):100-7. PubMed ID: 17544962 [TBL] [Abstract][Full Text] [Related]
8. Bilateral epibulbar pseudorheumatoid nodulosis with a review of ocular adnexal palisading granulomas. Tieger MG; Jakobiec FA; Wolkow N; Ma L; Chang HP Surv Ophthalmol; 2019; 64(4):558-569. PubMed ID: 30772365 [TBL] [Abstract][Full Text] [Related]
9. Accelerated Nodulosis in a Patient With Rheumatoid Arthritis. Enginar AÜ; Nur H; Gilgil E; Kaçar C Arch Rheumatol; 2019 Jun; 34(2):225-228. PubMed ID: 31497770 [TBL] [Abstract][Full Text] [Related]
10. Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series. Talotta R; Atzeni F; Batticciotto A; Ditto MC; Gerardi MC; Sarzi-Puttini P J Med Case Rep; 2018 Jun; 12(1):154. PubMed ID: 29859543 [TBL] [Abstract][Full Text] [Related]
11. [Development of multiple subcutaneous nodules in a patient with rheumatoid arthritis during methotrexate therapy]. Watanabe F; Yoshida T; Akizuki M; Mukai M Ryumachi; 1993 Feb; 33(1):74-9. PubMed ID: 8493588 [TBL] [Abstract][Full Text] [Related]
12. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Sokka T; Pincus T Arthritis Rheum; 2003 Feb; 48(2):313-8. PubMed ID: 12571838 [TBL] [Abstract][Full Text] [Related]
13. Impact of treatment with infliximab on serum cytokine profile of patients with rheumatoid and psoriatic arthritis. Amital H; Barak V; Winkler RE; Rubinow A Ann N Y Acad Sci; 2007 Sep; 1110():649-60. PubMed ID: 17911480 [TBL] [Abstract][Full Text] [Related]
14. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Wolfe F; Michaud K Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349 [TBL] [Abstract][Full Text] [Related]
15. Treatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexate. Harley CR; Frytak JR; Tandon N Am J Manag Care; 2003 Oct; 9(6 Suppl):S136-43. PubMed ID: 14577718 [TBL] [Abstract][Full Text] [Related]
16. Azathioprine-induced accelerated cutaneous and pulmonary nodulosis in a patient with rheumatoid arthritis. Kellet CV; Navarrete RA; Bombardieri SG; Manriquez J An Bras Dermatol; 2015; 90(3 Suppl 1):162-4. PubMed ID: 26312704 [TBL] [Abstract][Full Text] [Related]
17. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258 [TBL] [Abstract][Full Text] [Related]
18. True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha? Buch MH; Conaghan PG; Quinn MA; Bingham SJ; Veale D; Emery P Ann Rheum Dis; 2004 Oct; 63(10):1344-6. PubMed ID: 15033655 [TBL] [Abstract][Full Text] [Related]
19. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Lee JH; Slifman NR; Gershon SK; Edwards ET; Schwieterman WD; Siegel JN; Wise RP; Brown SL; Udall JN; Braun MM Arthritis Rheum; 2002 Oct; 46(10):2565-70. PubMed ID: 12384912 [TBL] [Abstract][Full Text] [Related]
20. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]